Aker BioMarine Management
Management criteria checks 3/4
Aker BioMarine's CEO is Matts Johansen, appointed in Jul 2015, has a tenure of 9.5 years. total yearly compensation is $688.81K, comprised of 61% salary and 39% bonuses, including company stock and options. directly owns 1.25% of the company’s shares, worth NOK71.17M. The average tenure of the management team and the board of directors is 3.3 years and 3.8 years respectively.
Key information
Matts Johansen
Chief executive officer
US$688.8k
Total compensation
| CEO salary percentage | 61.0% |
| CEO tenure | 9.5yrs |
| CEO ownership | 1.2% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Aker BioMarine AS' (OB:AKBM) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Dec 20
Aker BioMarine (OB:AKBM) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 08Aker BioMarine AS' (OB:AKBM) Revenues Are Not Doing Enough For Some Investors
Nov 05At kr102, Is It Time To Put Aker BioMarine AS (OB:AKBM) On Your Watch List?
Aug 20Optimistic Investors Push Aker BioMarine AS (OB:AKBM) Shares Up 25% But Growth Is Lacking
Jul 19What Does The Future Hold For Aker BioMarine AS (OB:AKBM)? These Analysts Have Been Cutting Their Estimates
Jul 16There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Jul 11These 4 Measures Indicate That Aker BioMarine (OB:AKBM) Is Using Debt In A Risky Way
Jun 03There's No Escaping Aker BioMarine AS' (OB:AKBM) Muted Revenues
Feb 15There Are Reasons To Feel Uneasy About Aker BioMarine's (OB:AKBM) Returns On Capital
Nov 06Estimating The Fair Value Of Aker BioMarine AS (OB:AKBM)
Sep 06We Think You Should Be Aware Of Some Concerning Factors In Aker BioMarine's (OB:AKBM) Earnings
Nov 04Aker BioMarine AS' (OB:AKBM) Has Found A Path To Profitability
Apr 13Aker BioMarine AS (OB:AKBM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Feb 18Loss-Making Aker BioMarine AS (OB:AKBM) Set To Breakeven
Jan 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3m |
| Jun 30 2024 | n/a | n/a | -US$11m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | US$689k | US$420k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$15m |
| Jun 30 2023 | n/a | n/a | -US$300k |
| Mar 31 2023 | n/a | n/a | US$14m |
| Dec 31 2022 | US$410k | US$401k | US$10m |
| Sep 30 2022 | n/a | n/a | US$1m |
| Jun 30 2022 | n/a | n/a | US$10m |
| Mar 31 2022 | n/a | n/a | -US$8m |
| Dec 31 2021 | US$467k | US$459k | -US$8m |
| Sep 30 2021 | n/a | n/a | US$3m |
| Jun 30 2021 | n/a | n/a | -US$8m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$630k | US$420k | -US$5m |
| Sep 30 2020 | n/a | n/a | -US$26m |
| Jun 30 2020 | n/a | n/a | -US$28m |
| Mar 31 2020 | n/a | n/a | -US$18m |
| Dec 31 2019 | US$660k | US$450k | -US$24m |
Compensation vs Market: Matts's total compensation ($USD688.81K) is above average for companies of similar size in the Norwegian market ($USD459.03K).
Compensation vs Earnings: Matts's compensation has been consistent with company performance over the past year.
CEO
Matts Johansen (48 yo)
9.5yrs
Tenure
US$688,813
Compensation
Mr. Matts Johansen serves as an Advisor at RunwayFBU AS. He has been Chief Executive Officer at Aker BioMarine ASA since July 1, 2015. He has been Chief Operating Officer of Aker Biomarine Antarctic AS sin...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 9.5yrs | US$688.81k | 1.25% NOK 71.2m | |
| Chief Financial Officer | 7yrs | US$378.29k | no data | |
| Chief Officer People & Communication | less than a year | US$221.24k | no data | |
| Chief Executive Officer of Emerging Business | no data | US$284.93k | no data | |
| Chief Operating Officer of Human Health Ingredients | no data | US$339.88k | no data | |
| Chief Executive Officer of Human Health Ingredients | 3yrs | US$306.31k | no data | |
| Chief Executive Officer of Lang Pharma Nutrition Inc | 3.3yrs | US$834.94k | no data | |
| Vice President of IR & Corporate Finance | no data | no data | no data | |
| Financial Controller | no data | no data | no data |
3.3yrs
Average Tenure
Experienced Management: AKBM's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Deputy Director | no data | no data | no data | |
| Director | no data | US$30.76k | no data | |
| Independent Director | 3.8yrs | US$48.75k | no data | |
| Chairman | 11yrs | US$70.05k | 0.98% NOK 55.8m | |
| Director | 3.8yrs | US$30.76k | no data | |
| Employee Representative Director | 5.4yrs | no data | no data | |
| Director | 2.8yrs | US$30.76k | 0.0046% NOK 259.9k | |
| Employee Representative Director | 1.6yrs | no data | 0.0040% NOK 225.1k | |
| Employee Representative Director | 1.6yrs | no data | no data |
3.8yrs
Average Tenure
53yo
Average Age
Experienced Board: AKBM's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 00:57 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aker BioMarine AS is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Ole-Andreas Krohn | DNB Markets |
| Ola Trovatn | DNB Markets |